| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/19/2012 | CA2805294A1 Compounds for the reduction of beta-amyloid production |
| 01/19/2012 | CA2805219A1 Pyrazole compound |
| 01/19/2012 | CA2805091A1 Pharmaceutical compositions and methods of treatment |
| 01/19/2012 | CA2804716A1 Chemical compounds |
| 01/19/2012 | CA2804351A1 Chemical compounds |
| 01/19/2012 | CA2800971A1 Chemical compounds |
| 01/19/2012 | CA2771928A1 Oxazine derivatives and their use in the treatment of neurological disorders |
| 01/19/2012 | CA2768199A1 (+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof |
| 01/18/2012 | EP2407536A1 ADP-ribosyl transferase fusion variant proteins |
| 01/18/2012 | EP2407473A2 Method for producing phosphorus-containing compounds |
| 01/18/2012 | EP2407466A1 Piperazine compound capable of inhibiting prostaglandin d synthase |
| 01/18/2012 | EP2407451A1 N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors |
| 01/18/2012 | EP2407167A2 Therapeutic agent for neurodegenerative disease |
| 01/18/2012 | EP2406266A1 7-cycloalkylaminoquinolones as gsk-3 inhibitors |
| 01/18/2012 | EP2406265A2 Substituted 3-aminoisoxazolopyridines as kcnq2/3 modulators |
| 01/18/2012 | EP2406264A2 Substituted heterocycles and their use as allosteric modulators of nicotinic and gabaa receptors |
| 01/18/2012 | EP2406238A1 Metal ion chelating agents, methods for preparing same and uses thereof |
| 01/18/2012 | EP2406229A1 Substituted 2-mercaptoquinoline-3-carboxamides as kcnq2/3 modulators |
| 01/18/2012 | EP2406228A1 Substituted 3-amino-2-mercaptoquinolines as kcnq2/3 modulators |
| 01/18/2012 | EP2406224A1 Substituted 2-mercapto-3-aminopyridines as kcnq2/3 modulators |
| 01/18/2012 | EP2406217A1 Tricyclic heterocyclic derivatives |
| 01/18/2012 | EP2406206A1 Tetrahydronaphthalen-2-ol derivatives |
| 01/18/2012 | EP2405967A2 Implantable device for long-term delivery of drugs |
| 01/18/2012 | EP2405922A1 Nutritional composition inducing a postprandial endocrine response |
| 01/18/2012 | EP2405920A1 Novel therapy for anxiety |
| 01/18/2012 | EP2405915A1 Immediate release pharmaceutical compositions comprising oxycodone and naloxone |
| 01/18/2012 | EP2405914A1 Compositions and methods for prophylaxis and treatment of addictions |
| 01/18/2012 | EP2405912A2 Method of disease-induced and receptor-mediated stem cell neuroprotection |
| 01/18/2012 | EP2405890A2 Riluzole aqueous suspensions |
| 01/18/2012 | EP2405749A1 Low frequency glatiramer acetate therapy |
| 01/18/2012 | EP2327413A9 Pharmaceutical composition comprising FGF18 and IL-1 antagonist and method of use |
| 01/18/2012 | EP2300424B1 Use of indole derivatives as nurr-1 activators for treating parkinson s disease |
| 01/18/2012 | EP1992618B1 Polycyclic cinnamide derivative |
| 01/18/2012 | EP1919907B9 Heterocyclic compound |
| 01/18/2012 | EP1808446B1 Il-18 receptor antagonist and pharmaceutical composition containing the antagonist |
| 01/18/2012 | EP1713780B1 Novel inhibitors of glutaminyl cyclase |
| 01/18/2012 | EP1513499B1 Ibuprofen suspension |
| 01/18/2012 | EP1506196B1 Pyrazolopyrimidines as sodium channel inhibitors |
| 01/18/2012 | EP1430114B1 Prolactin induced increase in neural stem cell numbers and therapeutical use thereof |
| 01/18/2012 | EP1429844B1 Conjugate of perphenazine and gaba and uses thereof |
| 01/18/2012 | EP1392849B2 Yeast screens for agents affecting protein folding |
| 01/18/2012 | EP1123388B1 Transgenic c. elegans as a model organism for research into alzheimer's disease |
| 01/18/2012 | CN1950351B 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands |
| 01/18/2012 | CN102326083A Method for inhibiting neurodegeneration |
| 01/18/2012 | CN102325778A Nalmefene hydrochloride dihydrate |
| 01/18/2012 | CN102325775A (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives |
| 01/18/2012 | CN102325773A Derivatives of 6-cycloamino-2,3-di-pyridinyl-imidazo[1,2-b]-pyridazine, preparation and therapeutic application thereof |
| 01/18/2012 | CN102325770A Piperidine derivatives useful as orexin antagonists |
| 01/18/2012 | CN102325766A Heteroaryl substituted pyridazinone derivatives |
| 01/18/2012 | CN102325765A Novel substituted bicyclic heterocyclic compounds as gamma secretase modulators |
| 01/18/2012 | CN102321515A Yin-nourishing and yang-tonifying health-care wine and preparation method thereof |
| 01/18/2012 | CN102321204A Selenium resin load, and intermediate, preparation method and application thereof |
| 01/18/2012 | CN102321129A Stilbene glycoside injection and preparation process thereof |
| 01/18/2012 | CN102321023A Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride |
| 01/18/2012 | CN102321020A LXR receptor modulators |
| 01/18/2012 | CN102321007A Oxiracetam compound and preparation method as well as medicine composition thereof |
| 01/18/2012 | CN102320928A Eucommia active monomer compound as well as preparation method, pharmaceutical composition and application thereof |
| 01/18/2012 | CN102319437A Polymer conjugates of interferon-beta with enhanced biological potency |
| 01/18/2012 | CN102319421A Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs |
| 01/18/2012 | CN102319406A Medicament for treating tristimania |
| 01/18/2012 | CN102319394A Xingnaojing composition for injection and preparation method thereof |
| 01/18/2012 | CN102319382A Chinese medicine for treating carcinomatous pains |
| 01/18/2012 | CN102319366A Traditional Chinese drug preparation for treating gilles tourette syndrome |
| 01/18/2012 | CN102319355A Chinese medicinal formula for treating hyperactivity and preparation method for pills thereof |
| 01/18/2012 | CN102319305A Dormitive incense |
| 01/18/2012 | CN102319277A Method for preparing fumaria capreolata L. total alkaloid extract |
| 01/18/2012 | CN102319251A Aspirin and dipyridamole gastric floating capsule and preparation method thereof |
| 01/18/2012 | CN102319240A Application of deacetylmycoepoxydiene serving as Hsp90 inhibitor |
| 01/18/2012 | CN102319239A Application of ainsliaidimer A in preparing nucleolus transcription factor inhibitor medicament |
| 01/18/2012 | CN102319227A Lomerizine hydrochloride osmotic pump tablet and preparation method thereof |
| 01/18/2012 | CN102319226A Reboxetine mesylate microencapsule tablet and preparation method thereof |
| 01/18/2012 | CN102319206A Stable aqueous solution of recombinant human interleukin-11, and preparation method thereof |
| 01/18/2012 | CN102319192A Enzyme bathing material for clearing toxins of human body and preparation method thereof |
| 01/18/2012 | CN102085279B Anti-anxiety pharmaceutical composition |
| 01/18/2012 | CN102018668B Preparation method of aceglutamide |
| 01/18/2012 | CN101912496B Method for preparing betelnut total alkaloids |
| 01/18/2012 | CN101884623B Levodopa methyl ester slow-release microsphere composition and preparation method thereof |
| 01/18/2012 | CN101884622B Benserazide sustained-release microspherical composition and preparation method thereof |
| 01/18/2012 | CN101863871B Total glycosides of Rhodiola rosea, medical application and preparation method thereof |
| 01/18/2012 | CN101810644B Production method of ant essential oil and ant oil soft capsule |
| 01/18/2012 | CN101797243B Composition containing levodopa and borneol, and application thereof |
| 01/18/2012 | CN101712669B Method for separating and purifying luteolin |
| 01/18/2012 | CN101674829B Use of 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of spinal cord traumas |
| 01/18/2012 | CN101524493B Multifunctional Chinese medicine honeyed pill |
| 01/18/2012 | CN101390871B Ginsenoside Rb1 containing impurity ginsenoside Rd |
| 01/17/2012 | US8097652 AMPA receptor potentiators |
| 01/17/2012 | US8097647 Augmented cognitive training |
| 01/17/2012 | US8097621 Pyrazolo[4,3-d]pyrimidines as phosphodiesterase inhibitors |
| 01/17/2012 | US8097617 Organic compounds |
| 01/17/2012 | US8097585 Methods of treating inflammation by administration of heme oxygenase-1 and products of heme degradation |
| 01/17/2012 | US8097279 Chewable soft capsule |
| 01/17/2012 | CA2657594C Pyrrolotriazine kinase inhibitors |
| 01/17/2012 | CA2534202C Lipid glycerides for the treatment of neurodegenerative conditions involving demyelination |
| 01/17/2012 | CA2517390C Chroman-derived anti-androgens for treatment of androgen-mediated disorders |
| 01/17/2012 | CA2504269C Piperazinyl and diazapanyl benzamides and benzthioamides |
| 01/17/2012 | CA2473986C Indazole compounds useful as protein kinase inhibitors |
| 01/17/2012 | CA2465007C Methods and means for producing proteins with predetermined post-translational modifications |
| 01/17/2012 | CA2451244C Purine derivatives as a2b adenosine receptor antagonists |
| 01/17/2012 | CA2441958C Il-28 polypeptides and polynucleotids |
| 01/17/2012 | CA2385456C 9-(piperazinylalkyl) carbazoles as bax-modulators |